Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer
NCT00984048
Observational
Unknown status
This is a multicenter translational study to understand therapeutic resistance in patients
undergoing first-line chemotherapy (FOLFOX/Avastin, or FOLFIRI/Avastin) for metastatic
colorectal cancer. Tissue samples from liver metastasis will be collected and banked before
the start of chemotherapy and at the time of progression. Additionally, blood samples will be
drawn monthly and stored in the tissue biobank.
Aug 31,2009
All
18 Years
N/A
18 Years
N/A
160